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ABSTRACT
The increasing use of nanotechnology in consumer products and medical applications underlies the importance of understanding its potential
toxic effects to people and the environment. Although both fullerene and carbon nanotubes have been demonstrated to accumulate to cytotoxic
levels within organs of various animal models and cell types and carbon nanomaterials have been exploited for cancer therapies, the molecular
and cellular mechanisms for cytotoxicity of this class of nanomaterial are not yet fully apparent. To address this question, we have performed
whole genome expression array analysis and high content image analysis based phenotypic measurements on human skin fibroblast cell
populations exposed to multiwall carbon nano-onions (MWCNOs) and multiwall carbon nanotubes (MWCNTs). Here we demonstrate that exposing
cells to MWCNOs and MWCNTs at cytotoxic doses induces cell cycle arrest and increases apoptosis/necrosis. Expression array analysis
indicates that multiple cellular pathways are perturbed after exposure to these nanomaterials at these doses, with material-specific toxigenomic
profiles observed. Moreover, there are also distinct qualitative and quantitative differences in gene expression profiles, with each material at
different dosage levels (6 and 0.6 íg/mL for MWCNO and 0.6 and 0.06 íg/mL for MWCNT). MWCNO and MWCNT exposure activates genes
involved in cellular transport, metabolism, cell cycle regulation, and stress response. MWCNTs induce genes indicative of a strong immune
and inflammatory response within skin fibroblasts, while MWCNO changes are concentrated in genes induced in response to external stimuli.
Promoter analysis of the microarray results demonstrate that interferon and p38/ERK-MAPK cascades are critical pathway components in the
induced signal transduction contributing to the more adverse effects observed upon exposure to MWCNTs as compared to MWCNOs.
Introduction. The emerging field of nanotechnology is part
of a new industrial revolution being applied to a diverse array
of consumer products and medical applications, ranging from
cosmetics to electronics and to drug delivery vehicles. With
this revolution, methods to reduce the potential toxic effects
of nanoparticles both in the environment and for medical
applications should be addressed (for review see Colvin1 and
Science Highlights2-4). Defining any potential toxicity will
aid the nanotechnology industry to minimize the environment-
al impact of nanomaterials, leading to reduced concern from
the public and policymakers and a more successful industry.
Carbon nanomaterials,5-7 including carbon nanoparticles
and nanotubes, have been one of the most extensively used
nanoparticles, because of their unique and superior properties,
including large surface areas, high electrical conductivity, and
excellent strength. Multiwall carbon nanotubes (MWCNTs)
and multiwall carbon nano-onions (MWCNOs), which will
be the focus of this study, represent a relatively recently
discovered allotrope of carbon derived from the more
intensively studied fullerene (C60).8,9 Single-walled,10 double-
walled,11 and multiwalled12 carbon nanotubes, with their
diverse chemical and physical properties, have led them to
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components, catalyst supports, electronic displays, to drug
delivery, and may even be used for hydrogen storage.9,10,13-16
Giant, nested fullerenes, generally called nano-onions (MWC-
NOs),17,18 comprise the least studied class of carbon nano-
particles. MWCNOs are usually produced by an underwater
carbon-arc discharge.19-21 Our arc-produced MWCNOs are
typically about 30 nm in diameter.22 Although the applica-
tions of MWCNOs have lagged behind those of MWCNTs,
they have been used as components of nanocomposites for
applications including solar cells, light-emitting devices,23,24
and fuel-cell electrodes.25
The increase in commercial interest of nanomaterials and
their subsequent production en masse will lead to greater
potential for exposure to individuals. Fortunately, aerosol
release of the MWCNOs and MWCNTs during manufactur-
ing is limited.26 However, because of the increase use, the
risk associated with exposure and the molecular mechanisms
of any cytotoxicity need to be well understood. Some of the
primary questions that should be addressed include the
following: (i) what are likely routes and location of exposure,
(ii) what are the molecular mechanisms of toxicity induced
by exposure, (iii) does observed toxicity correlate most to
size, shape, or composition, (iv) is there any concentration-
dependent toxicity, and (v) are byproducts of production or
decomposition toxic. The scientific community is beginning
to address these concerns, but information is scant. To date,
most toxicity studies have been performed on ultrafine
particles, which, interestingly, are more toxic than equivalent
micrometer-sized material.27 Other studies, however, have
demonstrated that toxicity is more highly correlated with
particle composition and surface chemistry rather than size.28
Recently, single-walled carbon nanotubes (SWCNTs) have
been demonstrated to be an effective infrared photosensitizer
for cancer cells,29 a n daC 2B10 carborane cage-coated
SWCNT has been constructed as the delivery vehicle for
boron neutron capture therapy for cancer.30 Fullerene has
been suggested to be a promising carcinotoxic chemical.28,31
Therefore, we speculate that multiwalled carbon nanomate-
rials such as MWCNO and MWCNT will be more effective
cancer killing agents than the SWCNT and single-walled
fullerene. It is even more important for us to decipher the
cytotoxicity and molecular mechanism of the multiwalled
carbon nanomaterials.
Early studies have indicated that a repeated subchronic
topical dose of fullerenes on mouse skin for up to 24 weeks,
after initiation with a polycyclic aromatic hydrocarbon, does
not result in either benign or malignant skin tumors, in
contrast to development of benign skin tumors when a
phorbol ester control is used for promotion.32 More recent
studies have begun to indicate some adverse effects from
carbon nanomaterial exposure. For example, water-soluble
fullerenes demonstrate cytotoxicity as a function of surface
derivatization28 and C60 derivative molecules also demon-
strate superoxide dismutase mimetic properties in Jurkat
cells.33,34 In addition, fullerenes induce oxidative stress in
the brains of juvenile largemouth bass,35 possibly through
free radical generation. Oberdo ¨rster has demonstrated that
inhaled nanosized carbon particles accumulate in the nasal
cavities, lungs, and brains of rats. The suggested route of
migration of these nanomaterials into the brain was from
lung to blood to brain where they were speculated to
accumulate and cause inflammation, brain damage, or central
nervous system disorders.35,36 It has also been reported that
there is an increased susceptibility to blood clotting in rabbits
inhaling carbon nanospheres.27 Validation of this toxicity
comes from studies in vitro, using nanosized diesel exhaust
particles (DEP). DEP, which includes carbon nanoparticles,
selectively damages dopaminergic neurons through the
phagocytic activation of microglial NADPH oxidase and
consequential oxidative insult.37
Lam and co-workers have demonstrated that inhaled
MWCNTs are more toxic than carbon black and quartz, thus
posing a serious occupational health hazard for people who
are chronically exposed.38 Monteiro-Riviere and colleagues
report that at all examined time points, chemically unmodi-
fied MWCNTs were present within cytoplasmic vacuoles of
exposed kerotinocytes HEK.39 In addition, MWCNT exposed
HEK cells released interleukin-8, a pro-inflammatory cy-
tokine. This release was postulated to result in the skin
irritation associated with exposure. In a separate study,
epidermal keratinocytes exposed to MWCNTs demonstrated
free radical generation, accumulation of peroxidative prod-
ucts, and antioxidant depletion, all indicators of oxidative
stress.40 Observations of exposed cells also indicated mor-
phological changes and reduced cell viability.40 These data
indicate that dermal exposure to unrefined SWCNTs may
lead to dermal toxicity due to accelerated oxidative stress in
the exposed skin.40 SWCNT exposures by intratracheal
installation in rats also produced transient inflammatory and
cell injury. When rat lungs were exposed to SWCNTs, a
series of multifocal granulomas were induced, both nonuni-
form in distribution and in a non-dose-dependent fashion,
indicative of a foreign tissue body reaction.41
Evidence thus far suggests that the key factors contributing
to nanomaterial-related cytotoxicity are size/mass, shape,
surface charge, and surface functionalization. The cytotox-
icity with equal mass basis shows an order of: SWNTs >
MWNT10 > C60.42 Investigations with 2 nm gold nanopar-
ticles in different cell types, tested by MTT, hemolysis, and
bacterial viability assays, showed that surface charge was a
key factor in inducing toxicity. This indicates that cationic
nanoparticles are moderately toxic and have an immediate
toxic effect at the blood/brain barrier, whereas anionic
particles are relatively nontoxic.43,44 Different surface coatings
also have been shown to change the cytotoxicity profiles of
quantum dots (CdSe nanocrystals) dramatically, and modi-
fications may attenuate the toxicity.45
As the exact molecular mechanisms for the damages
inflicted are still not fully understood, the above-mentioned
analyses have demonstrated the urgency of a more thorough
molecular characterization of nanomaterial toxicity. Expres-
sion array analysis and phenotypic measurements of exposed
cell populations may provide insight into the mechanisms
responsible for adverse events observed in these models. For
example, a recent preliminary unpublished investigation
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toxicity of nanoscale materials46 and, thus, the potential
benefit for using microarray technology to perform high
throughput characterization of nanomaterial toxigenomics.
In this study, the goal was to assess if changes in gene
expression in cells exposed to carbon-based nanomaterials
shows a correlation to phenotypic observations. Reported
here are two approaches to evaluate toxicity in nanomaterial
exposed cells: (i) the measurement of phenotypic changes
in large populations of cells by high content analysis and
(ii) gene expression array analysis in exposed cells. Pheno-
typically, cells exposed to high concentrations of nanoma-
terials were observed to undergo apoptosis/necrosis with a
concomitant reduction in proliferation indicative of an
inflammation response. We found that carbon nanomaterials
generated mRNA level changes in exposed skin fibroblasts,
including changes in mRNA levels from genes involved in
metabolism, apoptosis, cell cycle, stress response, cellular
transport, and inflammatory response. Of interest was our
observation that many of the genes that increased in
expression in nanomaterial-exposed cells are often associated
with a type I interferon response, which is known to be
activated during viral infection and lead to antiviral and
antiproliferative responses. Promoter analysis, derived from
gene expression data, indicates that the primary mechanism
for cell effects from MWCNO and MWCNT treatment is
through the p38/ERK MAPK kinase and interferon response
pathways. Of interest is the observation that MWCNTs
appear to induce a greater amount of stress upon the cells
than MWCNOs, even though the dosage is 1/10 by weight/
volume concentration. This may have far reaching ramifica-
tions for the deployment of specific types of nanomaterials
in the future. Clearly this study underscores the importance
of the potential toxic side effects in this burgeoning field.
Materials and Methods. Details for materials and meth-
ods can be found in the Supporting Information. The carbon
MWCNOs used in this study were produced by using a
modified direct-current electric-arc discharge method19 (Fig-
ure 1). The multiwalled carbon nanotubes (MWCNTs) were
synthesized by using a chemical vapor deposition (CVD)
method47 (Figure 1). Cellomics-based high content image
analysis (HCA) has been used for phenotypical measurement
of cell apoptosis, necrosis, cell numbers, proliferation, and
cell cycle distribution. Apoptotic cells and necrotic cells were
detected using DNA dyes that only traverse membranes of
necrotic or apoptotic cells.48 The DNA stain, YO-PRO-1 can
transverse the slightly permeable membranes of apoptotic
cells while propidium iodide requires the greater membrane
permeability of necrotic cells. An Affymetrix high-through-
put analysis (HTA) automated GeneChip system was used
for acquisition of the microarray data for the gene expression
profiling. Target preparation, washing, and staining have been
performed on an Affymetrix/Caliper robotic system, and
scanning was performed on a CCD-based Affymetrix high
throughput (HT) scanner, which is a fully automated epif-
lourescent imaging system. More details for the HTA
protocols can be found in the Supporting Information. Data
analysis has been performed using GeneSpring, Bioconduc-
tor, GeneTraffic, Cluster 3.0, PAINT, GoMiner, and Path-
wayAssist, with more details in Supporting Information.
Results. In Vitro Toxicity. Human skin fibroblasts (HSF42)
(Figures 2and 3) and human embryonic lung fibroblasts
(IMR-90) (Supporting Information Figure S1), both untrans-
formed cells, were used to evaluate the cytotoxic and
proliferative effects of carbon nanomaterials. Lung and skin
cells were selected because entry through the skin or respir-
atory tract is the most likely route of exposure to nanoma-
terials. Cells were added to 96-well plates (BD Biosciences),
grown to approximately 70% confluency in a CO2 incubator,
and then exposed to several concentrations of MWCNOs and
MWCNTs (Figure 1). To determine the cytotoxic dose to
be used for this study, cells were treated with serial dilutions
of MWCNO and MWCNT (data not shown), and we chose
doses of 0.6 and 6 mg/L for MWCNO and doses of 0.06
and 0.6 mg/L for MWCNT, so that the cells show ap-
proximately 2-fold increase in apoptosis/necrosis from the
untreated baseline cells and a 50% reduction in proliferation
(measured by end point cell numbers) after a treatment of
48 h at the low dose. The 2-fold increase of apoptosis/
necrosis from the baseline is an artificially defined point, an
approach previously used.49 The high doses are chosen as
10 times that of the low dose, so that pronounced gene
expression changes can be observed to mimic the acute
exposure to carbon nanomaterials. Cells were exposed for
24 or 48 h and counted, and various measurements were
made to evaluate cytotoxicity and proliferation. The MWCNTs
seem to be 10 times more toxic than the MWCNOs, which
is the reason that the amount of MWCNTs used in our studies
is only one-tenth that of the amount of MWCNOs used, at
both the low dose and high dose levels.
Cell counts were obtained by staining live cells with
Hoechst 33342 (Sigma), 48 h post-treatment, and then using
high content imaging in the KineticScan (KSR, Cellomics,
Pittsburgh, PA) to visualize the cells. Hoechst will stain DNA
in both live and dead cells; however the intensity of staining
is higher in apoptotic cells because of the condensed
chromosomes. The image analysis software, Cell Health
Profiling (Cellomics), was then used with the images
obtained with the KSR to identify and count cells. The bars
in the graphs in Figure 2A and Supporting Information Figure
S1 show cell numbers. This graph demonstrates that treat-
ment with either the MWCNOs or MWCNTs reduces cell
number in a dose-dependent fashion, with the higher
concentrations of MWCNTs creating the greatest effect
(Figure 2). This reduction in cell number could result from
apoptosis/necrosis and/or reduced proliferation.
Apoptosis and Necrosis. Cytotoxicity was evaluated by
staining live cells for 30 min with YO-PRO 1 (Invitrogen,
Molecular Probes), propidium iodide (PI, Sigma), and
Hoechst. Live cells are impermeable to YO-PRO 1 and PI,
both of which are intercalating DNA dyes. Apoptotic cells
are permeable to YO-PRO 1, while PI only stains necrotic
cells.48 Stained culture plates were analyzed using the KSR
and images were acquired at each appropriate fluorescence
channel for Hoechst, YO-PRO 1, and PI. The image analysis
software establishes average and total intensity for each
2450 Nano Lett., Vol. 5, No. 12, 2005nucleus in all channels. In the experiments pictured in Figure
2, wells were exposed to either the indicated concentration
of nanomaterials or the same volume of ethanol solvent as
a control, both kept at less than 1% of the total volume. Ten
replicates were done for each condition with intensities for
both YO-PRO 1 and PI averaged by well, to obtain the bars
in Figure 2B. Student t-tests indicated that all treatment
groups demonstrated significant differences from the control
group, with p < 0.01.
The following observations were made: (1) Apoptosis and
necrosis were observed for both MWCNO and MWCNT
treated cells with MWCNTs having the most detrimental
effect on both types of cells at the highest concentration
(Figure 2). (2) MWCNO treatment to lung fibroblasts,
however, demonstrated less of an effect as compared to
treatment of skin fibroblasts (Figure 2 and Supporting
Information Figure S1). (3) Skin fibroblasts treated with the
higher concentration of MWCNOs demonstrated a cell count
less than half of that observed in the control, more closely
reflecting the results obtained with MWCNT treatment
(Figure 2). (4) The average intensity of YO-PRO 1 and
propidium iodide staining in the cell types treated with both
MWCNOs and MWCNTs went up in a dose-dependent
manner (Figure 2) with one exception. The exception is
average YO-PRO 1 staining in MWCNO-treated skin
fibroblasts, and it remains similar at both concentrations. The
PI staining, however, gains intensity at the higher concentra-
tion of MWCNOs, indicating a greater number of necrotic
cells. These observations indicate the induction of apoptosis
and necrosis in nanomaterial-treated cells that is dose and
material dependent. It cannot be ruled out that some of the
reduction in cell number was a result of reduced proliferation,
so this was also tested.
Cell Proliferation. Proliferation was measured in skin
fibroblasts by incorporating BrdU for 30 min, fixing cells,
staining for BrdU with an antibody, and then counterstaining
Figure 1. Scanning electron microscopy (SEM) images and high-resolution transmission electron microscopy (HRTEM) images of carbon
nanomaterials used in this study. (A) SEM image of multiwalled carbon nanotubes (scale bar ) 200 nm). (B) SEM image of carbon
nano-onions (scale bar ) 200 nm). (C) HRTEM images of multiwalled carbon nanotubes (MWCNTs) (scale bar ) 5 nm). (D) HRTEM
images of multiwalled carbon nano-onions (MWCNO) (scale bar ) 10 nm).
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generated by the KSR for image analysis, with PI staining
pictured in channel 1, BrdU antibody staining in channel 2,
and the composite pictured in the middle. After images from
stained culture plates were obtained using the KSR, intensity
measurements for both BrdU and DNA staining were made
for each identified cell to generate a scatter plot with the
intensity of BrdU antibody staining on the Y-axis and PI in-
tensity on the X-axis. Analysis of these scatter plots allowed
us to obtain percentages of cells in G0/G1, S, and G2/M
phases during cell cycle (Figure 3B). Data from these scatter
plots are summarized in Figure 3C as a ratio of the percent-
ages of cells in each phase of the cell cycle in treated cells
as compared to control cells. The ratio of treated to control
cells in G0/G1 is very close to 1.00, suggesting that
nanomaterial treatment does not induce a block in G1. Ratios
of cells in S-phase of treated to control were also similar,
with a Student t-test demonstrating borderline significance.
The p-values for both nanomaterial treatments were both
slightly over 0.05. The largest difference in ratio, ap-
proximately 1:1.2 for both treatments, was in G2/M (Figure
3C), indicating a possible G2/M block and S phase delay
during cell cycle.
The results outlined above indicate that the reduction in
cell number is due to both apoptosis/necrosis and a possible
G2/M block. As measured by Student t-test and percentage
change from control, apoptosis/necrosis appears to be a more
significant mechanism for the reduced cell number after
nanomaterial treatment. These results are consistent with
other studies done with water-soluble fullerenes28,38,41,51 and
toxicity studies using MWCNTs.40
Gene Expression. Treating human skin fibroblast with
carbon nanomaterials induced profound gene expression
changes. Gene expression profiling was performed with the
new generation Affymetrix HTA GeneChip system. Figure
4A lists numbers of genes whose expression levels changed
after treatment with different particles and doses. We
compared gene expression changes using different doses of
the same particle structure (Figure 4B,C). These data indicate
that, although higher doses induced a greater number of genes
expression changes than low doses, there are no global dose-
dependent responses to both particles. This is demonstrated
by the small portion of genes that were changed commonly
at both low and high doses (Figure 4B,C, Supporting
Information Tables S2 and S5). The data indicated that
distinct pathways were activated in cells treated with low
dose or high dose nanomaterials. This is a phenomenon
reported before for other cellular stress factors; we have
observed similar qualitative differences between carefully
chosen low and high doses of radiation.49
We also compared genes that demonstrate altered expres-
sion after treatment with different types of carbon nanoma-
terials (Figure 4D,E). The number of genes in the area of
intersection in the Venn diagram in parts D and E of Figure
4 indicates a large percentage of genes show a common
expression changes after treatment with both types of
particles (Supporting Inormation Tables S8 and S11).
However, unique genes were also induced in response to
MWCNO or MWCNT and more genes demonstrated changes
in levels of expression at the lower concentration of
MWCNOs than that with lower concentration MWCNT
treatment (Figure 4). Interestingly, it is the dosage of carbon
nanomaterials that appears to have the greatest influence on
gene expression changes in common between MWCNOs and
MWCNTs, not the specific nanomaterial. This could be
Figure 2. Cell viability measurements after treatment with carbon nanomaterials at cytotoxic doses. Cells were plated on 96-well plates,
treated for 48 h, and then stained with Hoechst (nucleus stain for cell number indicator), YO-PRO 1 (apoptosis indicator) and PI (necrosis
indicator). Plates were transported to KineticScan (KSR, Cellomics, Pittsburgh, PA) for image collection, then automated analysis was
performed on the collected images. (A) The number of skin fibroblast cells per well 48 h after mock treatment with ethanol or treatment
with either MWCNOs (NO) or nanotubes (NT). The numbers of low doses (0.6 íg/mL for MWCNO and 0.06 íg/mL for MWCNT) and
high doses (6 íg/mL for MWCNO and 0.6 íg/mL for MWCNT) represent the nanomaterial concentration used for treatment. Bars represent
the mean of cell numbers from 10 imaged viewfields in 10 treated wells, and error bars represent a 95% confidence interval. Each nuclei
imaged by the KSR was identified with the Cell Health Profiling software in the blue channel by Hoechst staining. (B) YO-PRO 1 is
visualized in the green channel and PI is visualized in the red channel, where measurement such as dye intensity and area can be made
using the Cell Health Profiling algorithm. Average intensity of YO-PRO 1 intensity and PI intensity of mock treated and treated skin
fibroblasts at 48 h. The YO-PRO 1 intensity is proportional to apoptosis and the PI intensity correlates to necrosis. Bars represent the mean
of cell numbers from eight treated wells and the error bars represent a 95% confidence interval. Data for lung fibroblast treated under the
same condition are presented in Supporting Information Figure S1.
2452 Nano Lett., Vol. 5, No. 12, 2005similar to the threshold effect that is observed after cells are
treated with other insults, such as radiation.49
Specific Transcriptional Changes. Genes that demonstrated
expression level changes after nanoparticle treatment were
placed into functional categories, evaluated for statistical
significance, and then sorted by significance (Table 1). The
top 10 categories are listed in Table 1 with the percentages
of genes over- and underexpressed calculated. At the low
dose, MWCNO and MWCNT treatment caused expression
changes in similar groups of genes, including Golgi vesicle
transport, secretory pathway, fatty acid biosynthesis, protein
metabolism, and G1/S transition of mitotic cell cycle (Table
1), with down-regulated genes dominating in all of these
categories. An additional group of genes, involved in protein
ubiquitination, were up-regulated (Supporting information
Table S13). These data suggest that when cells are treated
with a low dose of carbon nanomaterials there is decreased
cell growth and metabolism, but increased protein degrada-
tion. Conversely, treatment with both MWCNOs and
MWCNTs at high dosages induced up-regulated genes in
tRNA aminoacylation and amino acid metabolism pathways,
indicating positive regulation of amino acid and protein
biosynthesis.
Changes in the expression of functionally related genes
were found at high doses of CMWNT treatment. These
included genes involved in the inflammatory and immune
Figure 3. Measurement of cell proliferation after treatment with carbon nanomaterials at cytotoxic doses. Cells were plated on 96-well
plates, treated, pulsed with BrdU, fixed, and then stained with anti-BrdU and PI. Plates were transported to the KSR for image collection
and then automated analysis was performed on the collected images. (A) Images generated by the KSR. Channel 1 is images of PI stained
nuclei, and this is used for cell identification, counting, and DNA content. Channel 2 represents BrdU staining, and this shows cells that
have passed through the S-phase during the pulse with BrdU. The composite image is also shown. (B) Typical scatter plot of BrdU staining
intensity versus PI intensity. This is used for calculating the number of cells in G0/G1, S, and G2/M phases. (C) Summary of cell cycle data
for nanomaterial-treated cells as compared to controls. An average of 20 000 cells were measured for each treatment condition.
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be ascribed to the innate immune system and generally are
induced in response to interferon (IFN) and the defense
against virus. STAT1 (for signal transduction and activator
of transcription-1) (Table 5) is activated by a number of
different ligands, including interferon-alpha (IFNA), interferon-
gamma (IFNG), and IL6 52 and in turn regulates IFN7
production. Treatment with MWCNTs up-regulates STAT1
leading to an observed IRF7 induction in these cells. IFN7
was recently demonstrated to regulate all elements of IFN
responses, including the systemic production of IFN in innate
immunity.53 IRF1, also up-regulated, has been demonstrated
to play an important role in transcription activation of type
I IFN genes.54 Additionally, most of the genes in Table 2
are IFN inducible including ADAR,55 CXCL10,56,57 G1P2,58
G1P3,59 IFI44, IFIT1,60 IFIT2,61 IFIT3,62 and IFIT563 among
others (Table 2). Several induced genes are also specifically
associated with an antiviral response including MX1, MX2,
OAS1, OAS2, and OAS3. The MX proteins are related to
an interferon-regulated mouse protein induced by influenza
virus,64,65 and the OAS proteins have been observed to be
induced as a response to the yellow fever vaccine.66,67 These
data indicate that MWCNTs may interact with cells differ-
ently than MWCNOs, and this type of interaction influences
the cellular response. On the basis of the large number of
genes associated with cellular response to viral infection and
an IFN type I response, MWCNT treatment may mimic viral
infection in some respects.
Many of the genes altered in expression after treatment
with the lower concentration of nanomaterials are those
Figure 4. (A) Numbers of genes whose expression levels changed after treatment with carbon nanomaterials at cytotoxic doses. (B-E)
Venn diagrams comparing numbers of genes that showed expression changes. Each Venn diagram is divided into three areas and labeled
as I, II, and III. Area II is the overlapping area of two circles, representing commonly changed genes in both conditions. Area I and III
represent genes that changed only in the condition specified in the circle. Bioconductor software was used to perform significance analysis
to determine the difference between expression levels in treated sample, and the control sample possesses statistical significance. The
empirical Bayesian model was used with Bonferroni’s multitest correction. The cutoff of p-values produced through the analysis was
determined by at least 10 times less than the p-values of the smallest p-value of control probe sets on the chip. (B) Comparing different
doses for the nano-onions. (C) Comparing different doses for the nanotubes. (D) Comparing different particles at low doses (0.6 íg/mL for
MWCNO and 0.06 íg/mL for MWCNT). (E) Comparing different particles at high doses (6 íg/mL for MWCNO and 0.6 íg/mL for
MWCNT).
2454 Nano Lett., Vol. 5, No. 12, 2005involved in transport, membrane fusion, and secretion (Table
3). These genes did not show discernible changes in expres-
sion with higher concentrations of MWCNOs and MWCNTs.
Many of the genes in this category, SNAP23, NAPG, NAPA
and GBF1, are involved in the process of docking and fusion
of vesicles to their target membranes.68-71 Most of the genes
in this category are underexpressed indicating that the cells
may be slowing secretion of proteins. Treatment of cells with
the lower concentrations of nanomaterials also has an impact
on the expression of cell cycle genes (Table 4) and genes in-
volved in ubiquitination (Supporting information Table S13).
Again, many of these genes are down-regulated, indicat-
ing a slowing of cell proliferation and protein degradation.
Table 5 lists genes involved in apoptosis that were induced
or repressed with nanomaterial treatment. A greater number
of genes involved in apoptosis were observed to be up-
regulated with MWCNT treatment at the higher dose,
possibly explaining the greater number of apoptotic and dead
cells observed with high content screening (Figure 2). Of
interest was the up-regulation of the cytokine and TNF family
member, TNFRSF10B (TRAILR2) in cells treated with the
highest concentration of MWCNTs, which is known to
induce apoptosis.72 Also, the RIPK273 gene contributes to
the induction of apoptosis and was observed to be up-
regulated in these treated cells. At lower doses, many of the
genes related to apoptosis listed in Table 5 are down-
regulated and are anti-apoptotic; examples include EGFR,74
MCL1,75 BCL2L1,76 and CRKL.77 Up-regulation of YARS
was observed with both nanomaterial treatments, especially
Table 1. Most Significantly Changed Gene Categories after Treating HSF42 Cells with Carbon Nanomaterials at Cytotoxic Dosesa
gene category p-value
%
underexpressed
%
overexpressed
carbon nano-onion Golgi vesicle transport 0.0000 8.51 2.13
0.6 íg/mL membrane fusion 0.0002 15.79 0.00
secretory pathway 0.0003 4.35 1.09
protein ubiquitination 0.0139 0.68 2.05
intracellular transport 0.0166 1.23 0.62
cell growth and/or maintenance 0.0201 0.66 0.27
fatty acid biosynthesis 0.0208 5.71 0.00
protein metabolism 0.0323 0.71 0.29
ubiquitin cycle 0.0342 0.70 1.06
G1/S transition of mitotic cell cycle 0.0361 4.26 0.00
carbon nanotube Golgi vesicle transport 0.0007 4.26 2.13
0.06 íg/mL protein metabolism 0.0020 0.65 0.18
secretory pathway 0.0049 2.17 1.09
fatty acid biosynthesis 0.0076 5.71 0.00
G1/S transition of mitotic cell cycle 0.0135 4.26 0.00
protein ubiquitination 0.0174 0.68 1.37
mitotic cell cycle 0.0200 1.95 0.00
ubiquitin cycle 0.0214 0.70 0.70
cell homeostasis 0.0228 3.23 0.00
protein prenylation 0.0262 14.29 0.00
carbon nano-onion L-serine metabolism 0.0000 0.00 40.00
6 íg/mL tRNA aminoacylation 0.0000 0.00 23.81
amine metabolism 0.0000 0.00 5.42
amine transport 0.0000 0.00 12.20
dicarboxylic acid transport 0.0020 0.00 25.00
response to extracellular stimulus 0.0063 0.00 14.29
heterocycle metabolism 0.0076 0.00 6.38
porphyrin metabolism 0.0139 0.00 9.52
TGF beta receptor signaling pathway 0.0139 4.76 4.76
pigment metabolism 0.0194 0.00 8.00
carbon nanotube tRNA aminoacylation 0.0000 0.00 33.33
0.6 íg/mL L-serine metabolism 0.0000 0.00 50.00
amine metabolism 0.0000 0.00 6.90
amine transport 0.0000 0.00 14.63
response to stimulus 0.0000 0.16 2.86
immune response 0.0000 0.18 4.50
water-soluble vitamin biosynthesis 0.0024 0.00 40.00
inflammatory response 0.0034 0.00 5.06
heterocycle metabolism 0.0062 2.13 6.38
dicarboxylic acid transport 0.0065 0.00 25.00
a The categories are generated by the GoMiner program (Materials and Methods, Supporting Information), using p-values as the evaluation criteria of
statistically significant changes. for each category. The p-value was calculated by conducting a two-sided Fisher’s exact test, which reflects the statistical
significance for that category being enriched in changed genes. The p-values were used to sort categories to identify those gene functional groups that have
responded the most after treatments.
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tribute to apoptosis by arresting translation and producing
cytokines.78
Large numbers of stimuli response genes were observed
to be up-regulated with the higher concentration of nano-
materials (Table 6). These include the immune response
genes pictured in Table 2. A few were down-regulated in
this category, including FOS,79 which is related to an increase
in cell proliferation. Again, most of the observed transcrip-
tional changes were observed with treatment with MWCNTs
at high concentration, although stimulus response genes were
also induced with MWCNO treatment. These results point
to a concerted cellular reaction to offset a cellular insult from
the addition of nanomaterials, with the greatest response
being observed with MWCNT treatment at the higher
concentration. This is consistent with the greatest phenotypic
response with respect to apoptosis, cell death, and prolifera-
tion also being observed at the higher concentration of
nanomaterials.
Promoter Analysis. According to our analysis of regulatory
elements (cis elements) within the promoters of genes altered
in expression upon carbon nanomaterial treatment, different
pathways appear to be activated depending upon the nano-
material dosage. As gene expression patterns observed in
microarray experiments reflect the activity of transcription
factors (TFs) in trans, we can trace back the regulatory
cascades upstream of the physiological effect. This is
performed by identifying the enriched transcription regulatory
elements (TRE) on the promoters of genes demonstrating
altered expression profiles. These analyses were performed
using the microarray data from MWCNT- and MWCNO-
treated HSF cells at low and high dosages.
Promoter analysis of the predominantly down-regulated
genes at the lower dosages points to the enrichment of EGR1-
(KROX1), GATA4, ELK1, and USF regulatory elements in
cells treated with MWCNO versus GATA4, ELK1, and USF
regulatory elements in cells treated with MWCNTs (Figure
5). Promoters in genes of up-regulated transcripts demon-
strate the enrichment of EGR1 binding elements. However,
the transcription of EGR1 is down-regulated after MWCNO
treatment indicating that up-regulation of some transcripts
may be a consequence of relieved repression as opposed to
activation. GATA4, EGR1, USF, and ELK1 TFs have all
been shown to be phosphorylated and activated by ERK and
p38 MAPK cascades.80-86 The down-regulation of these TFs
may reflect the down-regulation of the MAPK cascades. This
hypothesis is partially validated by the observation that p38
(MAPK14) expression is down-regulated in both experiments
with lower dosages of MWCNOs and MWCNTs.
Treatment of cells with higher dosages of carbon particles
caused a more pronounced effect on gene expression than
lower dosages. More transcripts are up-regulated as opposed
to down-regulated (Figure 5). The promoters of up-regulated
genes in MWCNT treated cells are enriched with IRFs,
ETS1, PPAR and EGR1 regulatory elements while MWCNO
treated cells are enriched with C/EBPdelta, E2F1, and EGR1
regulatory elements (Figure 5). Mechanistically, cells treated
with both of the higher doses of carbon nanomaterials appear
Table 2. Immune-Response and Inflammatory Genes that Over- or Underexpressed after Treating HSF42 Cells with Cytotoxic Dose
(0.6 íg/mL) of Multiwall Carbon Nanotubes
gene symbol gene name fold changea
ADAR adenosine deaminase, RNA-specific 1.44
BDKRB1 bradykinin receptor B1 1.59
CEBPB CCAAT/enhancer binding protein (C/EBP), beta 1.53
CXCL10 chemokine (C-X-C motif) ligand 10 4.82
CXCL3 chemokine (C-X-C motif) ligand 3 2.71
G1P2 interferon, alpha-inducible protein (clone IFI-15K) 2.51
G1P3 interferon, alpha-inducible protein (clone IFI-6-16) 2.03
IFI44 interferon-induced protein 44 3.50
IFIT1 interferon-induced protein with tetratricopeptide repeats 1 6.99
IFIT2 interferon-induced protein with tetratricopeptide repeats 2 5.99
IFIT3 interferon-induced protein with tetratricopeptide repeats 3 5.85
IFIT5 interferon-induced protein with tetratricopeptide repeats 5 1.76
IRF1 interferon regulatory factor 1 2.02
IRF7 interferon regulatory factor 7 2.47
ISGF3G interferon-stimulated transcription factor 3, gamma 48kDa 1.55
LIF leukemia inhibitory factor (cholinergic differentiation factor) 2.67
MGST2 microsomal glutathione S-transferase 2 0.67
MX1 Homo sapiens myxovirus (influenza) resistance 1 11.18
MX2 myxovirus (influenza virus) resistance 2 (mouse) 6.88
NFE2L1 nuclear factor (erythroid-derived 2)-like 1 1.70
NR4A2 nuclear receptor subfamily 4, group A, member 2 3.26
OAS1 2¢,5¢-oligoadenylate synthetase 1, 40/46kDa 2.82
OAS2 2¢,5¢-oligoadenylate synthetase 2, 69/71kDa 2.79
OAS3 2¢,5¢-oligoadenylate synthetase 3, 100kDa 2.21
RIPK2 receptor-interacting serine-threonine kinase 2 1.45
TNFAIP6 tumor necrosis factor, alpha-induced protein 6 1.82
a Fold changes represent the ratio of mRNA amount of treated samples divided by those of control samples.
2456 Nano Lett., Vol. 5, No. 12, 2005to trigger responses from the activated p38 and ERK MAPK
cascades, based on transcription factor profiling. In fact,
CCAAT enhancer binding protein delta (C/EBPdelta), en-
riched in MWCNO-treated cells, is a target of p38 MAPK87
and is associated with growth arrest in epithelial cells.88
However, the expression pattern of higher dose MWCNT
treatment differs significantly from that of MWCNO treat-
ment. For example, a robust IFN response is observed in
MWCNT-treated cells, but not in MWCNO-treated cells. The
presence of IRF elements contained within the promoters of
many of the up-regulated genes may explain this response.
In fact, IRF7 is one of the up-regulated genes observed (Table
2) and is believed to be central to an IFN response53 along
with STAT1 (Table 5), another up-regulated gene discussed
above, and one of the central signal transduction factors
needed for an IFN response. Transcriptional regulatory
elements present in the down-regulated genes of cells treated
with MWCNOs, such as GATA1, may also contribute to
the differences in gene transcription observed (Figure 5). FOS
gene expression is also reduced, leading to a lowered activity
of AP1 (FOS/JUN) transcription factors (Table 6). These
differences may be responsible for the difference in the
magnitude of response between these particles, observed
phenotypically by high content analysis. Additional experi-
ments monitoring the kinase activities should give us better
understanding the underlying mechanism.
Discussion. The results presented here show for the first
time both a phenotypic response of cells to carbon nanoma-
terials (apoptosis, necrosis, cell cycle perturbation, and
antiproliferation) and a global gene expression response at
a cellular level. Phenotypic effects were confirmed for two
different fibroblast cell types, human skin fibroblast (HSF,
Table 3. Genes Changed by Nano-Onion and Nanotube but Fall in the Category of “Transport” (Golgi Vesicle Transport, Membrane
Fusion, Secretory Pathway, Intracellular Transport)a
gene category
gene
symbol gene name
fold change
of gene expression
Fold Change of Gene Expression for Onion, 0.6 íg/mL
Golgi vesicle transport COPA coatomer protein complex, subunit alpha 0.57
SNAP23 synaptosomal-associated protein 0.30
GBF1 golgi-specific brefeldin A resistance factor 1 2.45
NAPG N-ethylmaleimide-sensitive factor attachment protein, gamma 0.48
NAPA N-ethylmaleimide sensitive fusion protein attachment protein alpha 0.60
membrane fusion NAPA N-ethylmaleimide sensitive fusion protein attachment protein alpha 0.60
NAPG N-ethylmaleimide-sensitive factor attachment protein, gamma 0.48
SNAP23 synaptosomal-associated protein 0.30
secretory pathway NAPA N-ethylmaleimide sensitive fusion protein attachment protein alpha 0.60
COPA coatomer protein complex, subunit alpha 0.57
GBF1 golgi-specific brefeldin A resistance factor 1 2.45
NAPG N-ethylmaleimide-sensitive factor attachment protein, gamma 0.48
SCD stearoyl-CoA desaturase 0.19
SNAP23 synaptosomal-associated protein 0.30
intracellular transport GBF1 golgi-specific brefeldin A resistance factor 1 2.45
DST dystonin 0.40
NAB2 NGFI-A binding protein 2 0.43
SNAP23 synaptosomal-associated protein 0.30
KDELR3 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention
receptor 3
0.76
NAPG N-ethylmaleimide-sensitive factor attachment protein, gamma 0.48
COPA coatomer protein complex, subunit alpha 0.57
HNRPA1 heterogeneous nuclear ribonucleoprotein A 1 2.49
NAPA N-ethylmaleimide sensitive fusion protein attachment protein alpha 0.60
nucleocytoplasmic NAB2 NGFI-A binding protein 2 0.43
transport HNRPA1 heterogeneous nuclear ribonucleoprotein A 1 2.49
Fold Change of Gene Expression for Tube, 0.06 íg/mL
Golgi vesicle transport COPA coatomer protein complex, subunit alpha 0.57
NAPA N-ethylmaleimide sensitive fusion protein attachment protein alpha 0.60
GBF1 Golgi-specific brefeldin A resistance factor 1 2.45
membrane fusion NAPA N-ethylmaleimide sensitive fusion protein attachment protein alpha 0.60
secretory pathway COPA coatomer protein complex, subunit alpha 0.57
NAPA N-ethylmaleimide sensitive fusion protein attachment protein alpha 0.60
SCD stearoyl-CoA desaturase 0.19
GBF1 Golgi-specific brefeldin A resistance factor 1 2.45
intracellular transport GBF1 Golgi-specific brefeldin A resistance factor 1 2.45
NAPA N-ethylmaleimide sensitive fusion protein attachment protein alpha 0.60
COPA coatomer protein complex, subunit alpha 0.57
a Fold change of gene expression is given for the low dose (0.6 íg/mL for MWCNO and 0.06 íg/mL for MWCNT). Fold changes represent the ratio of
MRNA amount of treated samples divided by those of control samples.
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Information Figure S1). This information will be important
for elucidating possible mechanisms responsible for the
toxicity observed after exposure to these particles. Important
to the validation of this experimental approach was to
determine if the microarray results were consistent with our
phenotypic observations of exposed cells by high content
analysis (HCA). The phenotypic responses of apoptosis, cell
death, and proliferation changes were predicted by changes
in expression levels of many of the genes we observed.
HCA of cells treated with MWCNOs and MWCNTs
showed significant changes in cell number that, upon further
investigation, was shown to be due to apoptosis, cell death,
and proliferation changes. Therefore nanomaterials do dem-
onstrate toxicity, especially at higher concentrations. MWCNTs
appear to be more toxic to cells than MWCNOs as
demonstrated by the greater number of cells undergoing
apoptosis or necrosis after treatment, even at one-tenth the
amount of the carbon nano-onions. This response, at least
with the MWCNT treatment may be due to a type I INF
response, which has been shown to lead to apoptosis and
cell death. This type of response also leads to changes in
cell proliferation, which were also observed. The phenotypic
response is dose-dependent, even though the molecular
mechanisms causing the phenotypic changes may be different
depending on the dose or particle type. The magnitude of
the response could be a reflection of differential pathway
activation (Figure 6). One limitation of this study is that it
has been performed on cells and not on whole organisms. A
living system may have several lines of defense to prevent
or minimize some of the toxic effects of exposure to small
particles. However, because toxicity has been indicated from
this analysis, workers that come in contact with large
amounts of nanomaterials should protect their skin and lungs
from potential exposure.
Gene expression changes in human skin fibroblasts serve
as readout for cellular responses to the stimulus of carbon
nanomaterials. By applying significance analysis with very
conservative Bonferroni multitesting correction, we found a
profound number of genes with statistically significant
Table 4. Genes Changed by Nano-Onion and Carbon Nanotubes but Fall in the Category of Cell Cycle Regulatory Genes (G1/S
Transition of Mitotic Cell Cycle, Mitotic Cell Cycle, and Cell Growth of Maintenance)a
gene category
gene
symbol gene name
fold change
of gene expression
Fold Change of Gene Expression for Nano-Onion
cell proliferation EXTL3 exostoses (multiple)-like 3 0.44
FGFR1 fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2,
Pfeiffer syndrome)
1.72
NAB2 NGFI-A binding protein 2 (EGR1 binding protein 2) 0.43
cell cycle DUSP1 dual specificity phosphatase 1 0.17
TRIM33 tripartite motif-containing 33 1.60
HSF1 heat shock transcription factor 1 0.52
BCAT1 branched chain aminotransferase 1, cytosolic 0.17
regulation of cell cycle SKP2 S-phase kinase-associated protein 2 (p45) 0.21
MCL1 myeloid cell leukemia sequence 1 (BCL2-related) 0.19
EGFR epidermal growth factor receptor (erythroblastic leukemia viral
(v-erb-b) oncogene homolog, avian)
0.24
MAPK14 mitogen-activated protein kinase 14 0.25
CRKL v-crk sarcoma virus CT10 oncogene homologue (avian)-like 0.20
cell cycle arrest MACF1 microtubule-actin cross-linking factor 1 1.81
DST dystonin 0.40
cell differentiation PDLIM7 PDZ and LIM domain 7 (enigma) 0.60
BSG basigin (OK blood group) 0.44
NAPA N-ethylmaleimide sensitive fusion protein attachment protein alpha 0.60
EGR1 early growth response 1 0.39
Fold Change of Gene Expression for Nanotube
cell proliferation FGFR1 fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2,
Pfeiffer syndrome)
1.72
cell cycle DUSP1 dual specificity phosphatase 1 0.23
BCAT1 branched chain aminotransferase 1, cytosolic 0.24
CDK2 cyclin-dependent kinase 2 0.58
regulation of cell cycle SKP2 S-phase kinase-associated protein 2 (p45) 0.18
MCL1 myeloid cell leukemia sequence 1 (BCL2-related) 0.18
MAPK14 mitogen-activated protein kinase 14 0.30
CRK v-crk sarcoma virus CT10 oncogene homologue (avian) 0.53
SLC12A4 solute carrier family 12 (potassium/chloride transporters), member 4 0.23
cell differentiation PDLIM7 PDZ and LIM domain 7 (enigma) 0.62
NAPA N-ethylmaleimide sensitive fusion protein attachment protein alpha 0.62
a Fold change of gene expression is given for the low dose (0.6 íg/mL for MWCNO and 0.06 íg/mL for MWCNT). Fold changes represent the ratio of
MRNA amount of treated samples divided by those of control samples.
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Table S1-S12). Treating cells with a high dose of carbon
particles caused more gene expression changes than the low
dose treatment (Figure 4). However, it would be misleading
to say that the responses were dose-dependent, at least for
the two doses in this study. As shown in parts B and C of
Figure 4, only a small portion of genes with altered
transcription were found in common between the low and
high dose profiles, when treating with same type of particle.
This indicates that distinct gene expression profiles were
induced at low and high dose treatment. In contrast, if we
compare two types of particles, they induced similar tran-
scriptional changes in cells at the same high and low doses
(Figure 4D,E). The unique genes flanking the overlapping
area in Figure 4D,E may indicate cellular responses unique
to exposure with MWCNOs or MWCNTs (Supporting
Information Tables S7, S9, S10, and S12).
Gene ontology analysis gave further evidence supporting
the qualitative differences of cell responses to low and high
doses of carbon nanomaterials. The percentages of overex-
pressed and underexpressed genes in the top 10 most changed
gene categories are shown in Table 1. At low dose of both
of MWCNO and MWCNT, genes were down-regulated in
most of the categories. Many of these genes involve Golgi
vesicle transport, secretory pathway, fatty acid biosynthesis,
protein metabolism, and G1/S transition of mitotic cell cycle.
The only up-regulated category was protein ubiquitination
(Table 1, Supporting Information Table 13). Collectively,
these data suggest a reduction of cell growth and metabolism
but an acceleration of protein degradation at the low dosage.
Reduction of cell growth was consistent with our phenotypic
data. In contrast, a high dose of MWCNO and MWCNT
resulted in the up-regulation of protein and amino acid
metabolism; with additional up-regulation of genes involved
in a type I IFN response (Table 1). The outcome is an
increase in apoptosis and reduction in cell growth. However,
the distinct gene expression profiles induced at low and high
doses may indicate that different mechanisms are responsible
for our phenotypic observations or that the response occurs
at a different rate and we are observing two “snapshots” of
a temporal progression of a single mechanism. This observa-
tion agrees with the our earlier experience with gene
expression changes induced by radiation.49
Structure-specific cellular responses were also observed
in this experiment. At high dose, only MWCNT caused
overexpression of a significant number of immune and
inflammatory response genes (Table 1 and Table 2). Totally
25 genes in this category were overexpressed and only one
gene was underexpressed, indicating a robust response of
this function group (Tables 1 and 2). Most of these genes
Table 5. Genes Changed by Nano-Onion and Carbon Nanotubes but Fall in the Category of Apoptosisa
gene symbol gene name
fold change of
gene expression
Fold Change of Gene Expression for 0.6 íg/mL MWCNO
EGFR epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b)
oncogene homolog, avian)
0.17
MCL1 myeloid cell leukemia sequence 1 (BCL2-related) 0.19
BCL2L1 BCL2-like 1 0.24
PPM1F protein phosphatase 1F (PP2C domain containing) 1.63
TGM2 transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) 0.35
FGFR1 fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) 1.72
CRKL v-crk sarcoma virus CT10 oncogene homologue (avian)-like 0.20
EXTL3 exostoses (multiple)-like 3 0.44
MAPK14 mitogen-activated protein kinase 14 0.31
MACF1 microtubule-actin cross-linking factor 1 1.81
Fold Change of Gene Expression for 0.06 íg/mL MWCNT
TGM2 transglutaminase 2 (C polypeptide, protein-glutamine-ç-glutamyltransferase) 0.40
MCL1 myeloid cell leukemia sequence 1 (BCL2-related) 0.18
FGFR1 fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) 1.72
CRK v-crk sarcoma virus CT10 oncogene homologue (avian) 0.48
MAPK14 mitogen-activated protein kinase 14 0.30
Fold Change of Gene Expression for 6 íg/mL MWCNO
YARS tyrosyl-tRNA synthetase 1.62
Fold Change of Gene Expression for 0.6 íg/mL MWCNT
YARS tyrosyl-tRNA synthetase 1.75
MX1 myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) 11.55
BIRC3 baculoviral IAP repeat-containing 3 2.16
RIPK2 receptor-interacting serine-threonine kinase 2 1.38
STAT1 signal transducer and activator of transcription 1, 91kDa 2.22
TNFAIP3 tumor necrosis factor, alpha-induced protein 3 1.95
AHR aryl hydrocarbon receptor 1.68
TNFRSF10B tumor necrosis factor receptor superfamily, member 10b 1.62
a Fold change of gene expression is given for the low dose (0.6 íg/mL for MWCNO and 0.06 íg/mL for MWCNT). Fold changes represent the ratio of
MRNA amount of treated samples divided by those of control samples.
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induced by interferon or interferon-related proteins. Many
of these genes are implicated in an interferon type I response,
which is potently antiviral and antiproliferative. Some of the
genes that are typically induced by an interferon type I
response include Irf7, Isgf3g, Stat1 Adar, Cxcl10, Irf1,
Isgf3g, IFIT1, and MX2, all found in Table 2. Interestingly
the dimension of carbon tubes is similar to that of a virus,
and the cellular response may mimic the response observed
with viral infection. Certainly the induction of many of the
same genes during viral infection is observed. Our observa-
tion fits a previous report that kerotinocytes (HEKs) exposed
to chemically unmodified MWCNTs released interleukin-8,
a pro-inflammatory cytokine, which was postulated to result
in the skin irritation associated with exposure.39
In addition to the IFN type I response genes, we also
observed up-regulation of intracellular aryl hydrocarbon
(AHR) in MWCNT-treated cells (Table 5). This gene is
typically expressed in cells or animals exposed to polycyclic
aromatic hydrocarbons and is believed to mediate the
teratogenesis, immune suppression, epithelial disorders, and
tumor production in exposed experimental animals.89 Tran-
scription of Bax, driven by AHR, is part of an evolutionarily
conserved cell-death-signaling pathway response, responsible
for ovarian failure induced by environmental toxins.90
Overexpression of this gene is consistent with the cell death
we observed with the carbon nanomaterials. In addition, the
cytokine and TNF family member TNFRSF10B (TRAILR2)
is up-regulated in cells treated with the highest concentration
of nanotubes, and this protein induces apoptosis in a wide
variety of cells.72 Additional apoptosis genes involved include
BCL2L2 and MCL1. Finally, RIPK2 and TNFAIP3, genes
that contribute to the induction of apoptosis, were also
observed to be up-regulated in these treated cells.
Table 6. Genes Changed by Nano-Onion and Carbon Nanotubes but Fall in the Category of External Stimuli Response Genesa
gene category gene symbol gene name
fold change of
gene expression
Fold Change of Gene Expression for MWCNO 6 mg/L
immune response EGR1 early growth response 1 0.37
FOS v-fos FBJ murine osteosarcoma viral oncogene homolog 0.14
stress response DDIT3 DNA-damage-inducible transcript 3 2.39
SLC3A2 solute carrier family 3 (activators of dibasic and neutral amino
acid transport), member 2
2.46
STC2 stanniocalcin 2 2.38
VEGF vascular endothelial growth factor 2.18
DDIT3 DNA-damage-inducible transcript 3 2.39
FOS v-fos FBJ murine osteosarcoma viral oncogene homolog 0.14
SQSTM1 sequestosome 1 2.00
VEGF vascular endothelial growth factor 2.18
Fold Change of Gene Expression for MWCNT 0.6 mg/L
immune response CXCL10 chemokine (C-X-C motif) ligand 10 4.82
IFIT2 interferon-induced protein with tetratricopeptide repeats 2 5.99
IFIT3 interferon-induced protein with tetratricopeptide repeats 3 5.85
IRF1 interferon regulatory factor 1 2.02
IRF7 interferon regulatory factor 7 2.47
CXCL3 chemokine (C-X-C motif) ligand 3 2.71
MX2 myxovirus (influenza virus) resistance 2 (mouse) 6.88
NR4A2 nuclear receptor subfamily 4, group A, member 2 2.62
PLSCR1 phospholipid scramblase 1 2.38
response to DNA damage DDIT3 DNA-damage-inducible transcript 3 2.70
stimulus IRF7 interferon regulatory factor 7 2.47
stress response CXCL10 chemokine (C-X-C motif) ligand 10 4.82
CXCL3 chemokine (C-X-C motif) ligand 3 2.71
DDIT3 DNA-damage-inducible transcript 3 2.70
IRF7 interferon regulatory factor 7 2.47
MKNK2 MAP kinase interacting serine/threonine kinase 2 2.11
MX2 myxovirus (influenza virus) resistance 2 (mouse) 6.88
NR4A2 nuclear receptor subfamily 4, group A, member 2 2.62
OAS1 2¢,5¢-oligoadenylate synthetase 1, 40/46 kDa 2.82
OAS2 2¢,5¢-oligoadenylate synthetase 2, 69/71 kDa 2.79
OAS3 2¢,5¢-oligoadenylate synthetase 3, 100 kDa 2.21
PLSCR1 phospholipid scramblase 1 2.38
SLC3A2 solute carrier family 3 (activators of dibasic and neutral amino
acid transport), member 2
2.58
STAT1 signal transducer and activator of transcription 1, 91 kDa 2.22
VEGF vascular endothelial growth factor 2.24
a Fold change of gene expression is given for the low dose (0.6 íg/mL for MWCNO and 0.06 íg/mL for MWCNT). Fold changes represent the ratio of
MRNA amount of treated samples divided by those of control samples.
2460 Nano Lett., Vol. 5, No. 12, 2005Data from Tables 4 and 5 indicate that FGFR1 and EGFR
are involved in the response. We suspect that the cells are
using strategies similar to a viral response when exposed to
nanomaterials. Viruses are very similar in size range to the
carbon nanomaterials used here, around 20 nm in diameter.
FGFR, EGFR, and other RTK pathways have been impli-
cated in viral response in numerous studies. An early step
in viral infection is the targeting of the virus to cell surface
Figure 5. Promoter analysis. The interaction matrix for the differentially expressed genes (horizontal) and transcription regulatory elements
(vertical) in the up- and down-regulated gene sets at different dosage using different carbon nanoparticles. The PAINT software (Supporting
Information) then computes p-values to look for the overrepresented TREs in the set of promoters analyzed in reference to all the genes in
the PAINT database to generate filtered (p-value < 0.1) interaction matrixes. Individual elements of the matrix are colored by the significance
p-values: over-representation in the matrix is colored in red. The brightest red represents low p-value (most significantly over-represented).
Enriched transcription regulatory elements for the nanoparticle dataset.
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ing signaling receptors such as EGFR, chemokine receptor,
platelet-derived growth factor receptor, fibroblast growth
factor receptor, tumor necrosis factor receptor family, and
various integrin receptors. Usually multiple receptors are
targeted by the virus for binding, signaling, and entry. Virus
also impinges upon the signal transduction pathway in the
sense that their binding to the receptor perturbs the normal
receptor-coupled signal transduction pathways. Many recep-
tors, e.g., EGFR, are potent stimulators of the mitogen-
activated protein kinase (MAPK) signaling pathway. Chronic
stimulation of EGFR and of multiple steps in the MAPK
signaling pathway is involved in multiple cellular processes,
especially in the interaction between viruses and tyrosine
kinase pathways.91 One interesting observation is the down-
regulation of EGFR by >4-fold, which indicates that the
nano-onion and nanotubes might serve as therapeutics for
EGFR-overexpressing epithelial cancers, such as >20% of
the breast cancer. This could be a very interesting use of the
cytotoxicity of the carbon nanomaterials, which has been
suggested28 and demonstrated by other groups.29 In addition
to regulation of EGFR and FGFR1 expression, the overex-
pression of VEGF mRNA is also observed at both high dose
experiments. The secretion of VEGF could be the cellular
wound healing response to the addition of nanoparticles. In
addition to the ability to activate epithelial proliferation, it
may also be a last-resort cellular response to save the
epithelial cells from apoptosis.92
Promoter analysis identified EGR1/Krox as one of the
over-represented transcription regulatory elements on up-
regulated genes in almost all experimental settings (Figure
5). In addition, with high dosage of treatment, additional
transcription factors (ETS1 and IRF for MWCNTs, E2F and
C/EBP-delta for MWCNOs) might be involved (Figure 5).
In general, the profiles of enriched TREs are dramatically
different in the individual experiments. For the down-
regulated genes from MWCNT treatment, there are enrich-
ment of GATA4, USF, and ELK1 at low dosage and COMP1
(cooperates with myogenic proteins 1) at higher dosage. For
the carbon onions treatment, the lower dosage is correlated
with enrichment of GATA4, USF, elk1, and Egr1/Knox in
down-regulated genes and high dosage with enrichment of
GATA1, HES1, PAX, and E2F1. The upstream events
leading to the different expression patterns seem to be related
to ERK and p38 MAPK activities and the induction of
interferon signaling. These analyses suggest that the induction
of the p38/ERK pathway and the type I IFN response are
the upstream signaling events (see Figure 6 for the pathway
analysis result illustration) responsible for changes in cellular
transcription due to MWCNO and MWCNT treatment of
cells. Indeed, the pathway responses shown here are similar
to the response of human bronchial epithelial cells to
combustion-derived metals.93
In summary, combined with the result from functional
analysis, this study clearly showed that at high dosage, carbon
particles can seriously impact the cellular functions in
maintenance, growth, and differentiation. Of these two
nanomaterials, MWCNTs appear to induce more stress on
the cells than MWCNOs. Our data suggest that there is a
qualitative difference in response to low dose and high dose
treatment of carbon particles in human skin fibroblasts.
Carbon tubes at high dose induced innate immune responses,
whereas carbon onions did not. This indicates that cells
respond differently according to the structures of nanoma-
terials. Our data also suggest that carbon atoms released from
nanomaterials may participate in cell metabolic pathways.
It is evident from our studies that carbon nanomaterials have
a toxic effect on lung and skin cells. As little as 15 000
MWCNOs per cell and a few dozen MWCNTs per cell
induced cell death in this study. Therefore, as this potentially
revolutionary technology is further developed, specific heed
must be given to minimizing unwanted effects upon both
producers and consumers. The regulation of p38/ERK and
the EGFR also opens the door that the carbon nano-onions
and potentially other carbon nanomaterials can be exploited
Figure 6. A comparison of activated signal transduction networks for higher dose responses to carbon tubes and carbon onions.
PathwayBuilder software (Arkin Group, LBNL) is used to analyze and create pathways differentially activated with the treatment matrix
based on published literature.
2462 Nano Lett., Vol. 5, No. 12, 2005as a nanomedicine platform for cancer therapy, especially
epithelially derived cancers.
Acknowledgment. We thank Mr. Kevin Peet and Ms.
Lonnette Robinson for excellent administrative support. We
thank Alistar McDonald for critical reading of the manuscript
and Professor Marc Shuman and Professor Song Li for
support. F. Chen was supported by NIH Grant R1CA95393-
01, DOD BCRP BC045345 Grant, DARPA, UCSF Prostate
Cancer SPORE award (NIH Grant P50 CA89520), by a DOE
LDRD grant to A. P. Alivisatos/J. W. Gray, and by NIH
P50 Grant CA112970 to J. W. Gray. This work was
performed under the auspices of the U.S. Department
of Energy, at the University of California/Lawrence
Berkeley National Laboratory, under Contract No. DE-AC03-
76SF00098.
Supporting Information Available: Details of materials
and methods discussed, figures showing cell viability mea-
surements and a scatter plot of normalized GeneChip data,
and tables listing the top 20 genes in Figure 4. This material
is available free of charge via the Internet at http://
pubs.acs.org.
References
(1) Colvin, V. L. The potential environmental impact of engineered
nanomaterials. Nat. Biotechnol. 2003, 21, 1166-1170.
(2) Service, R. F. American Chemical Society meeting. Nanomaterials
show signs of toxicity. Science 2003, 300, 243.
(3) Proffitt, F. Nanotechnology. Yellow light for nanotech. Science 2004,
305, 762.
(4) Service, R. F. Nanotoxicology. Nanotechnology grows up. Science
2004, 304, 1732-1734.
(5) Curl, R. F.; R. E., S.; Kroto, H. W.; O’Brien, S.; Heath, J. R. How
the news that we were not the first to conceive of soccer ball C60
got to us. J. Mol. Graphics Modell. 2001, 19, 185-186.
(6) Iijima, S. Helical microtubules of graphitic carbon. Nature 1991, 354,
56-58.
(7) Iijima, S.; Ichihashi, T. Single-shell carbon nanotubes of 1-nm
diameter. Nature 1993, 363, 603-605.
(8) Fullerenes: Chemistry, Physics, and Technology; Kadish, K. M.,
Ruoff, R. S., Eds.; Wiley-Interscience: New York, 2000.
(9) Dresselhaus, M. S.; Dresselhaus, G.; Eklund, P. C. Science of
Fullerenes and Carbon Nanotubes; Academic Press: New York,
1996.
(10) Ajayan, P. M. Nanotubes from Carbon. Chem. ReV. 1999, 99, 1787-
1799.
(11) Sugai, T.; et al. New Synthesis of High-Quality Double-Walled
Carbon Nanotubes by High-Temperature Pulsed Arc Discharge. Nano
Lett. 2003, 3, 769-773.
(12) Sinnott, S. B.; Andrews, R. Carbon Nanotubes: Synthesis, Properties
and Applications. Crit. ReV. Solid State Mater. Sci. 2001, 26, 145-
249.
(13) Tan, S. J.; et al. Individual single-wall carbon nanotubes as quantum
wires. Nature 1997, 386, 474-477.
(14) Colbert, D. T.; Smalley, R. E. Fullerene nanobutes for molecular
electronics. Trends. Biotechnol. 1999, 17,4 6 -50.
(15) White, C. T.; Todorov, T. N. Quantum electronics: Nanotubes go
ballistic. Nature 2001, 411, 649-651.
(16) Calvert, P. In Carbon Nanotubes 1997, 277-292.
(17) Iijima, S. Direct observation of the tetrahedral bonding in graphitized
carbon black by high-resolution electronmicroscopy. J. Cryst. Growth
1980, 50, 675-683.
(18) Ugarte, D. Onion-like graphitic particles. Carbon 1995, 33, 989-
993.
(19) Sano, N.; Wang, H.; Chhowalla, M.; Alexandrou, I.; Amaratunga,
G. A. J. Nanotechnology: Synthesis of carbon “onions” in water.
Nature (London) 2001, 414, 506-507.
(20) Sano, N.; et al. Properties of carbon onions produced by an arc
discharge in water. J. Appl. Phys. 2002, 92, 2783-2788.
(21) Lange, H.; et al. Nanocarbon production by arc discharge in water.
Carbon 2003, 41, 1617-1623.
(22) Chen, B.; Selegue, J. P.; Wijeratne, L.; Bom, D.; Meier, M. S.
Characterization of carbon nano-onions by using flow field-flow
fractionation. Proc. Carbon ¢02, Int. Conf. Carbon [ISBN 7-900362-
03-7]; 2002, 22.27.75.
(23) Choi, M. S.; Kim, Y.-J.; Yi, J.-H.; Altman, I.; Pikhitsa, P. U.S. Pat.
Appl. Publ. 10 pp. ((S. Korea). U.S.; 2004).
(24) Brabec, C.; Hirsch, A. PCT Int. Appl. 19 pp. ((Siemens Aktieng-
esellschaft, Germany). WO; 2003).
(25) Kajiura, H.; Shiraishi, S.; Negishi, E.; Ata, M.; Yamada, A. Jpn.
Kokai Tokkyo Koho 13 pp. ((Sony Corp.: Japan). Jp; 2001).
(26) Maynard, A. D.; et al. Exposure to carbon nanotube material: aerosol
release during the handling of unrefined single-walled carbon
nanotube material. J. Toxicol. EnViron. Health, Part A 2004, 67,8 7 -
107.
(27) Silva, V. M.; Corson, N.; Elder, A.; Oberdorster, G. The Rat Ear
Vein Model For Investigating In Vivo Thrombogenicity Of Ultrafine
Particles (Ufp). Toxicol. Sci. 2005.
(28) Sayes, C. M.; et al. The differential cytotoxicity of water-soluble
fullerenes. Nano Lett. 2004, 4, 1881-1887.
(29) Shi Kam, N. W.; O’Connell, M.; Wisdom, J. A.; Dai, H. Carbon
nanotubes as multifunctional biological transporters and near-infrared
agents for selective cancer cell destruction. Proc. Natl. Acad. Sci.
U.S.A. 2005, 102, 11600-11605.
(30) Yinghuai, Z.; et al. Substituted carborane-appended water-soluble
single-wall carbon nanotubes: new approach to boron neutron capture
therapy drug delivery. J. Am. Chem. Soc. 2005, 127, 9875-9880.
(31) Burlaka, A. P.; et al. Catalytic system of the reactive oxygen species
on the C60 fullerene basis. Exp. Oncol. 2004, 26, 326-327.
(32) Nelson, M. A.; et al. Effects of acute and subchronic exposure of
topically applied fullerene extracts on the mouse skin. Toxicol. Ind.
Health 1993, 9, 623-630.
(33) Ali, S. S.; et al. A biologically effective fullerene (C60) derivative
with superoxide dismutase mimetic properties. Free Radical. Biol.
Med. 2004, 37, 1191-1202.
(34) Rancan, F.; et al. Cytotoxicity and photocytotoxicity of a dendritic
C(60) monoadduct and a malonic acid C(60) tris-adduct on Jurkat
cells. J. Photochem. Photobiol., B 2002, 67, 157-162.
(35) Oberdorster, E. Manufactured nanomaterials (fullerenes, C60) induce
oxidative stress in the brain of juvenile largemouth bass. EnViron.
Health Perspect. 2004, 112, 1058-1062.
(36) Frampton, M. W.; et al. Effects of exposure to ultrafine carbon
particles in healthy subjects and subjects with asthma. Res. Rep.s
Health Eff. Inst. ; 2004, discussion 49-63, 1-47.
(37) Block, M. L.; et al. Nanometer size diesel exhaust particles are
selectively toxic to dopaminergic neurons: the role of microglia,
phagocytosis, and NADPH oxidase. FASEB J. 2004, 18, 1618-1620.
(38) Lam, C. W.; James, J. T.; McCluskey, R.; Hunter, R. L. Pulmonary
toxicity of single-wall carbon nanotubes in mice 7 and 90 days after
intratracheal instillation. Toxicol. Sci. 2004, 77, 126-134.
(39) Monteiro-Riviere, N. A.; Nemanich, R. J.; Inman, A. O.; Wang, Y.
Y.; Riviere, J. E. Multiwalled carbon nanotube interactions with
human epidermal keratinocytes. Toxicol. Lett. 2005, 155, 377-384.
(40) Shvedova, A. A.; et al. Exposure to carbon nanotube material:
assessment of nanotube cytotoxicity using human keratinocyte cells.
J. Toxicol. EnViron. Health, Part A 2003, 66, 1909-1926.
(41) Warheit, D. B.; et al. Comparative pulmonary toxicity assessment
of single-wall carbon nanotubes in rats. Toxicol. Sci. 2004, 77, 117-
125.
(42) Jia, G.; et al. Cytotoxicity of Carbon Nanomaterials: Single-Wall
Nanotube, Multi-Wall Nanotube, and Fullerene. 2005, 39, 1378-
1383.
(43) Goodman, C. M.; McCusker, C. D.; Yilmaz, T.; Rotello, V. M.
Toxicity of gold nanoparticles functionalized with cationic and
anionic side chains. Bioconjugate Chem. 2004, 15, 897-900.
(44) Lockman, P. R.; Koziara, J. M.; Mumper, R. J.; Allen, D. D.
Nanoparticle surface charges alter blood-brain barrier integrity and
permeability. J. Drug Targeting 2004, 12, 635-641.
(45) Kirchner, C.; et al. Cytotoxicity of colloidal CdSe and CdSe/ZnS
nanoparticles. Nano Lett. 2005, 5, 331-338.
(46) Cunningham, M. J.; Magnuson, S. R.; Falduto, M. T.; Balzano, L.;
Resasco, D. E. Investigating the toxicity of nanoscale materials by
gene expression profiling: A systems biology approach. American
Chemical Society Annual Meeting Presentation, 2005.
(47) Andrews, R.; Jacques, D.; Qian, D.; Rantell, T. Multiwall carbon
nanotubes: synthesis and application. Acc. Chem. Res. 2002, 35,
1008-1017.
Nano Lett., Vol. 5, No. 12, 2005 2463(48) Wronski, R.; Golob, N.; Grygar, E.; Windisch, M. Two-color,
fluorescence-based microplate assay for apoptosis detection. Bio-
techniques 2002, 32, 666-668.
(49) Ding, L. H.; et al. Gene expression profiles of normal human
fibroblasts after exposure to ionizing radiation: a comparative study
of low and high doses. Radiat. Res. 2005, 164,1 7 -26.
(50) Dolbeare, F.; Gratzner, H.; Pallavicini, M. G.; Gray, J. W. Flow
cytometric measurement of total DNA content and incorporated
bromodeoxyuridine. Proc. Natl. Acad. Sci. U.S.A. 1983, 80, 5573-
5577.
(51) Yang, X. L.; Fan, C. H.; Zhu, H. S. Photoinduced cytotoxicity of
malonic acid [C(60)]fullerene derivatives and its mechanism. Toxicol.
in Vitro 2002, 16,4 1 -46.
(52) Darnell, J. E., Jr.; Kerr, I. M.; Stark, G. R. Jak-STAT pathways and
transcriptional activation in response to IFNs and other extracellular
signaling proteins. Science 1994, 264, 1415-1421.
(53) Honda, K.; et al. IRF-7 is the master regulator of type-I interferon-
dependent immune responses. Nature 2005, 434, 772-777.
(54) Harada, H.; et al. Absence of the type I IFN system in EC cells:
transcriptional activator (IRF-1) and repressor (IRF-2) genes are
developmentally regulated. Cell 1990, 63, 303-312.
(55) Weier, H. U.; George, C. X.; Greulich, K. M.; Samuel, C. E. The
interferon-inducible, double-stranded RNA-specific adenosine deami-
nase gene (DSRAD) maps to human chromosome 1q21.1-21.2.
Genomics 1995, 30, 372-375.
(56) Luster, A. D.; Unkeless, J. C.; Ravetch, J. V. Gamma-interferon
transcriptionally regulates an early-response gene containing homol-
ogy to platelet proteins. Nature 1985, 315, 672-676.
(57) Luster, A. D.; Jhanwar, S. C.; Chaganti, R. S.; Kersey, J. H.; Ravetch,
J. V. Interferon-inducible gene maps to a chromosomal band
associated with a (4; 11) translocation in acute leukemia cells. Proc.
Natl. Acad. Sci. U.S.A. 1987, 84, 2868-2871.
(58) Clauss, I. M.; et al. Chromosomal localization of two human genes
inducible by interferons, double-stranded RNA, and viruses. Cyto-
genet. Cell Genet. 1990, 53, 166-168.
(59) Porter, A. C.; et al. Interferon response element of the human gene
1988,6 -16. EMBO J. 1988, 7,8 5 -92.
(60) Chebath, J.; Merlin, G.; Metz, R.; Benech, P.; Revel, M. Interferon-
induced 56 000 Mr protein and its mRNA in human cells: molecular
cloning and partial sequence of the cDNA. Nucleic. Acids Res. 1983,
11, 1213-1226.
(61) Lafage, M.; et al. The interferon- and virus-inducible IFI-56K and
IFI-54K genes are located on human chromosome 10 at bands q23-
q24. Genomics 1992, 13, 458-460.
(62) Zhu, H.; Cong, J. P.; Shenk, T. Use of differential display analysis
to assess the effect of human cytomegalovirus infection on the
accumulation of cellular RNAs: induction of interferon-responsive
RNAs. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 13985-13990.
(63) Niikura, T.; Hirata, R.; Weil, S. C. A novel interferon-inducible gene
expressed during myeloid differentiation. Blood Cells Mol. Dis. 1997,
23, 337-349.
(64) Horisberger, M. A.; et al. cDNA cloning and assignment to
chromosome 21 of IFI-78K gene, the human equivalent of murine
Mx gene. Somat Cell Mol. Genet 1988, 14, 123-131.
(65) Melen, K.; et al. Human MxB protein, an interferon-alpha-inducible
GTPase, contains a nuclear targeting signal and is localized in the
heterochromatin region beneath the nuclear envelope. J. Biol. Chem.
1996, 271, 23478-23486.
(66) Bonnevie-Nielsen, V.; Larsen, M. L.; Frifelt, J. J.; Michelsen, B.;
Lernmark, A. Association of IDDM and attenuated response of 2¢,5¢-
oligoadenylate synthetase to yellow fever vaccine. Diabetes 1989,
38, 1636-1642.
(67) Bonnevie-Nielsen, V.; et al. Variation in antiviral 2¢,5¢-oligoadenylate
synthetase (2¢5¢AS) enzyme activity is controlled by a single-
nucleotide polymorphism at a splice-acceptor site in the OAS1 gene.
Am. J. Hum. Genet. 2005, 76, 623-633.
(68) Whiteheart, S. W.; et al. SNAP family of NSF attachment proteins
includes a brain-specific isoform. Nature 1993, 362, 353-355.
(69) Lemons, P. P.; Chen, D.; Bernstein, A. M.; Bennett, M. K.;
Whiteheart, S. W. Regulated secretion in platelets: identification of
elements of the platelet exocytosis machinery. Blood 1997, 90, 1490-
1500.
(70) Ravichandran, V.; Chawla, A.; Roche, P. A. Identification of a novel
syntaxin- and synaptobrevin/VAMP-binding protein, SNAP-23,
expressed in nonneuronal tissues. J. Biol. Chem. 1996, 271, 13300-
13303.
(71) Mansour, S. J.; Herbrick, J. A.; Scherer, S. W.; Melancon, P. Human
GBF1 is a ubiquitously expressed gene of the sec7 domain family
mapping to 10q24. Genomics 1998, 54, 323-327.
(72) Walczak, H.; et al. TRAIL-R2: a novel apoptosis-mediating receptor
for TRAIL. EMBO J. 1997, 16, 5386-5397.
(73) McCarthy, J. V.; Ni, J.; Dixit, V. M. RIP2 is a novel NF-kappaB-
activating and cell death-inducing kinase. J. Biol. Chem. 1998, 273,
16968-16975.
(74) Sibilia, M.; et al. The EGF receptor provides an essential survival
signal for SOS-dependent skin tumor development. Cell 2000, 102,
211-220.
(75) Opferman, J. T.; et al. Development and maintenance of B and T
lymphocytes requires antiapoptotic MCL-1. Nature 2003, 426, 671-
676.
(76) Boise, L. H.; et al. bcl-x, a bcl-2-related gene that functions as a
dominant regulator of apoptotic cell death. Cell 1993, 74, 597-608.
(77) Senechal, K.; Halpern, J.; Sawyers, C. L. The CRKL adaptor protein
transforms fibroblasts and functions in transformation by the BCR-
ABL oncogene. J. Biol. Chem. 1996, 271, 23255-23261.
(78) Wakasugi, K.; Schimmel, P. Two distinct cytokines released from a
human aminoacyl-tRNA synthetase. Science 1999, 284, 147-151.
(79) Seshadri, T.; Campisi, J. Repression of c-fos transcription and an
altered genetic program in senescent human fibroblasts. Science 1990,
247, 205-209.
(80) Chuang, C. F.; Ng, S. Y. Functional divergence of the MAP kinase
pathway. ERK1 and ERK2 activate specific transcription factors.
FEBS Lett. 1994, 346, 229-234.
(81) Hipskind, R. A.; Baccarini, M.; Nordheim, A. Transient activation
of RAF-1, MEK, and ERK2 coincides kinetically with ternary
complex factor phosphorylation and immediate-early gene promoter
activity in vivo. Mol. Cell Biol. 1994, 14, 6219-6231.
(82) Hodge, C.; et al. Growth hormone stimulates phosphorylation and
activation of elk-1 and expression of c-fos, egr-1, and junB through
activation of extracellular signal-regulated kinases 1 and 2. J. Biol.
Chem. 1998, 273, 31327-31336.
(83) Lim, C. P.; Jain, N.; Cao, X. Stress-induced immediate-early gene,
egr-1, involves activation of p38/JNK1. Oncogene 1998, 16, 2915-
2926.
(84) Liang, Q.; et al. The transcription factor GATA4 is activated by
extracellular signal-regulated kinase 1- and 2-mediated phosphory-
lation of serine 105 in cardiomyocytes. Mol. Cell Biol. 2001, 21,
7460-7469.
(85) Kerkela, R.; Pikkarainen, S.; Majalahti-Palviainen, T.; Tokola, H.;
Ruskoaho, H. Distinct roles of mitogen-activated protein kinase
pathways in GATA-4 transcription factor-mediated regulation of
B-type natriuretic peptide gene. J. Biol. Chem. 2002, 277, 13752-
13760.
(86) Galibert, M. D.; Carreira, S.; Goding, C. R. The Usf-1 transcription
factor is a novel target for the stress-responsive p38 kinase and
mediates UV-induced Tyrosinase expression. EMBO J. 2001, 20,
5022-5031.
(87) Baldassare, J. J.; Bi, Y.; Bellone, C. J. The role of p38 mitogen-
activated protein kinase in IL-1 beta transcription. J. Immunol. 1999,
162, 5367-5373.
(88) O’Rourke, J.; Yuan, R.; DeWille, J. CCAAT/enhancer-binding
protein-delta (C/EBP-delta) is induced in growth-arrested mouse
mammary epithelial cells. J. Biol. Chem. 1997, 272, 6291-6296.
(89) Ohtake, F.; et al. Modulation of oestrogen receptor signaling by
association with the activated dioxin receptor. Nature 2003, 423,
545-550.
(90) Matikainen, T.; et al. Aromatic hydrocarbon receptor-driven Bax gene
expression is required for premature ovarian failure caused by
biohazardous environmental chemicals. Nat. Genet 2001, 28, 355-
360.
(91) Braun-Falco, M.; Eisenried, A.; Buning, H.; Ring, J. Recombinant
adeno-associated virus type 2-mediated gene transfer into human
keratinocytes is influenced by both the ubiquitin/proteasome pathway
and epidermal growth factor receptor tyrosine kinase. Arch. Dermatol.
Res. 2005, 296, 528-535.
(92) Alavi, A.; Hood, J. D.; Frausto, R.; Stupack, D. G.; Cheresh, D. A.
Role of Raf in vascular protection from distinct apoptotic stimuli.
Science 2003, 301,9 4 -96.
(93) Wu, W.; et al. Activation of the EGF receptor signaling pathway in
human airway epithelial cells exposed to metals. Am. J. Physiol. 1999,
277, L924-931.
NL051748O
2464 Nano Lett., Vol. 5, No. 12, 2005